Eden launches world's first compounded semaglutide gummy, offering GLP-1 benefits without needles.
In Denver on December 31, 2024, Eden unveiled the global debut of the first compounded semaglutide gummy. This gummy, available at tryeden.com, is crafted to provide the advantages of GLP-1 drugs in a user-friendly, needle-free form. This groundbreaking product transforms the way people engage with GLP-1 therapies.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments